Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study

Background—Daily administration of rectal formulations of mesalazine is effective in preventing relapse of ulcerative proctitis. Maintenance of remission with lower doses would be an advantage. 
Aim—The efficacy of mesalazine suppositories (Pentasa) 1 g three times a week v placebo to maintain remis...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Marteau, P, Crand, J, Foucault, M, Rambaud, J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1998
Témata:
Inflammatory Bowel Disease
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1727004/
https://ncbi.nlm.nih.gov/pubmed/9536943
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky